More than one reason to rethink the use of peptides in vaccine design (Q36808693)

16 August 2017

1 reference

title

More than one reason to rethink the use of peptides in vaccine design (English)

1 reference

16 August 2017

1 reference

1 reference

2

1 reference

16 August 2017

3

1 reference

16 August 2017

Anthony W Purcell

1

0 references

publication date

1 May 2007

1 reference

Nature Reviews Drug Discovery

16 August 2017

published in

1 reference

16 August 2017

volume

6

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

404-414

1 reference

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

16 August 2017

cites work

1 reference

A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition

31 March 2020

1 reference

Prediction of supertype-specific HLA class I binding peptides using support vector machines

31 March 2020

1 reference

A community resource benchmarking predictions of peptide binding to MHC-I molecules

31 March 2020

1 reference

Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design

31 March 2020

1 reference

A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus

31 March 2020

1 reference

Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules

31 March 2020

1 reference

SYFPEITHI: database for MHC ligands and peptide motifs

31 March 2020

1 reference

Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix.

31 March 2020

1 reference

Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network.

31 March 2020

1 reference

Post-translational modifications of naturally processed MHC-binding epitopes

31 March 2020

1 reference

Link between organ-specific antigen processing by 20S proteasomes and CD8(+) T cell-mediated autoimmunity

31 March 2020

1 reference

Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes

31 March 2020

1 reference

Have we cut ourselves too short in mapping CTL epitopes?

31 March 2020

1 reference

T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide

31 March 2020

1 reference

A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule

31 March 2020

1 reference

The insulin A-chain epitope recognized by human T cells is posttranslationally modified

31 March 2020

1 reference

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

31 March 2020

1 reference

Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin

31 March 2020

1 reference

Description and prediction of peptide-MHC binding: the 'human MHC project'.

31 March 2020

1 reference

Chemistry of peptides associated with MHC class I and class II molecules

31 March 2020

1 reference

Capture and processing of exogenous antigens for presentation on MHC molecules.

31 March 2020

1 reference

Toward a definition of self: proteomic evaluation of the class I peptide repertoire

31 March 2020

1 reference

High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance

31 March 2020

1 reference

Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle

31 March 2020

1 reference

Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa

31 March 2020

1 reference

Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501.

31 March 2020

1 reference

CTL recognition of a bulged viral peptide involves biased TCR selection

31 March 2020

1 reference

The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation

31 March 2020

1 reference

Cutting edge: unique T cells that recognize citrullinated peptides are a feature of protein immunization

31 March 2020

1 reference

Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.

31 March 2020

1 reference

Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis

31 March 2020

1 reference

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

31 March 2020

1 reference

Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein

31 March 2020

1 reference

Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL

31 March 2020

1 reference

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes

31 March 2020

1 reference

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

31 March 2020

1 reference

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

31 March 2020

1 reference

T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation

31 March 2020

1 reference

T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen

31 March 2020

1 reference

Post-translational modifications of self antigens: implications for autoimmunity

31 March 2020

1 reference

Tumors reveal their secrets to cytotoxic T cells

31 March 2020

1 reference

Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy

31 March 2020

1 reference

Immune recognition of a human renal cancer antigen through post-translational protein splicing.

31 March 2020

1 reference

An antigenic peptide produced by peptide splicing in the proteasome

31 March 2020

1 reference

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

31 March 2020

1 reference

Post-proteasomal antigen processing for major histocompatibility complex class I presentation

31 March 2020

1 reference

Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.

31 March 2020

1 reference

The peptide-loading complex and ligand selection during the assembly of HLA class I molecules.

31 March 2020

1 reference

Quantitative and qualitative influences of tapasin on the class I peptide repertoire.

31 March 2020

1 reference

Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor

31 March 2020

1 reference

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

31 March 2020

1 reference

HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading.

31 March 2020

1 reference

Endogenous and exogenous factors contributing to the surface expression of HLA B27 on mutant APC.

31 March 2020

1 reference

Optimization of the MHC class I peptide cargo is dependent on tapasin

31 March 2020

1 reference

Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion

31 March 2020

1 reference

A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence

31 March 2020

1 reference

Kb, Kd, and Ld molecules share common tapasin dependencies as determined using a novel epitope tag.

31 March 2020

1 reference

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide

31 March 2020

1 reference

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

31 March 2020

1 reference

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex

31 March 2020

1 reference

Heteroclitic immunization induces tumor immunity

31 March 2020

1 reference

Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein

31 March 2020

1 reference

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide

31 March 2020

1 reference

Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: implications for recognition by tumor-infiltrating lymphocytes.

31 March 2020

1 reference

Beta-amino acid scan of a class I major histocompatibility complex-restricted alloreactive T-cell epitope

31 March 2020

1 reference

T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo

31 March 2020

1 reference

Beta-amino acids: versatile peptidomimetics

31 March 2020

1 reference

Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration

31 March 2020

1 reference

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.

31 March 2020

1 reference

Design of peptide-based vaccines for cancer.

31 March 2020

1 reference

Peptides and peptidomimetics in medicine, surgery and biotechnology

31 March 2020

1 reference

Cancer vaccines: preclinical studies and novel strategies

31 March 2020

1 reference

A novel chemical approach to drug delivery: lipidic amino acid conjugates.

31 March 2020

1 reference

Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci

31 March 2020

1 reference

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

31 March 2020

1 reference

Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity

31 March 2020

1 reference

Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations

31 March 2020

1 reference

Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity

31 March 2020

1 reference

Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways

31 March 2020

1 reference

Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91.

31 March 2020

1 reference

Binding of antigenic peptide to the endoplasmic reticulum-resident protein gp96/GRP94 heat shock chaperone occurs in higher order complexes. Essential role of some aromatic amino acid residues in the peptide-binding site.

31 March 2020

1 reference

Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.

31 March 2020

1 reference

Vaccine adjuvants revisited

31 March 2020

1 reference

Lipid-based self-adjuvanting vaccines

31 March 2020

1 reference

GM-CSF-based cancer vaccines

31 March 2020

1 reference

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization

31 March 2020

1 reference

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

31 March 2020

1 reference

A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses

31 March 2020

1 reference

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma

31 March 2020

1 reference

ISCOM-based vaccines: the second decade.

31 March 2020

1 reference

Saponin-adjuvanted particulate vaccines for clinical use.

31 March 2020

1 reference

31 March 2020

1 reference

Dendritic cell-derived exosomes as cell-free peptide-based vaccines

31 March 2020

1 reference

Peptides delivered by immunostimulating reconstituted influenza virosomes

31 March 2020

1 reference

Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity

31 March 2020

1 reference

Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation

31 March 2020

1 reference

Cross-presentation: a general mechanism for CTL immunity and tolerance

31 March 2020

1 reference

Membrane ruffling, macropinocytosis and antigen presentation in the absence of gelsolin in murine dendritic cells

31 March 2020

1 reference

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

31 March 2020

1 reference

Cross-presentation: underlying mechanisms and role in immune surveillance

31 March 2020

1 reference

Roles of heat-shock proteins in antigen presentation and cross-presentation

31 March 2020

1 reference

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis

31 March 2020

1 reference

Use of proteomics to define targets of T-cell immunity

31 March 2020

1 reference

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

31 March 2020

1 reference

Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules

31 March 2020

1 reference

Peptide exchange in MHC molecules

31 March 2020

1 reference

Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments

31 March 2020

1 reference

Optimisation of peptide-based cytotoxic T-cell determinants using non-natural amino acids

31 March 2020

1 reference

Particulate systems as adjuvants and carriers for peptide and protein antigens

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD2224

1 reference

16 August 2017

1 reference